N-terminal pro-brain natriuretic peptide as a predictor of reoperation in children with surgically corrected tetralogy of fallot

Circulation Journal

Volumn 78, Issue 3, 2014, Pages 693-700

  Hirono, Keiichi ^a   Sekine, Michikazu ^a   Shiba, Noriko ^a   Hayashi, Shirou ^a   Nakaoka, Hideyuki ^a   Ibuki, Keijiro ^a   Saito, Kazuyoshi ^a   Watanabe, Kazuhiro ^a   Ozawa, Sayaka ^a   Higuma, Tomonori ^a   Yoshimura, Naoki ^a   Kitajima, Isao ^a   Ichida, Fukiko ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Brain natriuretic peptide; Heart failure; N terminal pro brain natriuretic peptide; Pulmonary valve replacement; Tetralogy of fallot

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CHILD; CONTROLLED STUDY; FALLOT TETRALOGY; FEMALE; HEART FAILURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; CLINICAL TRIAL; PATHOLOGY; PREDICTIVE VALUE; PRESCHOOL CHILD; REOPERATION; TETRALOGY OF FALLOT;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; REOPERATION; TETRALOGY OF FALLOT;

EID: 84894425301     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1048     Document Type: Article

References (31)

1. Bailliard F, Anderson RH. Tetralogy of Fallot. Orphanet J Rare Dis 2009; 4: 2.
2. Miyazaki A, Sakaguchi H, Ohuchi H, Matsuoka M, Komori A, Yamamoto T, et al. Efficacy of hemodynamic-based management of tachyarrhythmia after repair of tetralogy of Fallot. Circ J 2012; 76: 2855-2862.
3. Oechslin EN, Harrison DA, Harris L, Downar E, Webb GD, Siu SS, et al. Reoperation in adults with repair of tetralogy of Fallot: Indications and outcomes. J Thorac Cardiovasc Surg 1999; 118: 245-251.
4. Tulevski II, Groenink M, van Der Wall EE, van Veldhuisen DJ, Boomsma F, Stoker J, et al. Increased brain and atrial natriuretic peptides in patients with right ventricular pressure overload: Correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001; 86: 27-30.
5. Therrien J, Siu S, Harris L, Dore A, Niwa K, Janousek J, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103: 2489-2494.
6. Harrison DA, Siu SC, Hussain F, MacLoghlin CJ, Webb GD, Harris L. Sustained atrial arrhythmias in adults late after repair of tetralogy of Fallot. Am J Cardiol 2001; 87: 584-588.
7. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: A multicentre study. Lancet 2000; 356: 975-981.
8. Sonoda H, Ohte N, Goto T, Wakami K, Fukuta H, Kikuchi S, et al. Plasma N-terminal pro-brain natriuretic peptide levels identifying left ventricular diastolic dysfunction in patients with preserved ejection fraction. Circ J 2012; 76: 2599-2605.
9. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
10. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-832.
11. Hosoda K, Nakao K, Mukoyama M, Saito Y, Jougasaki M, Shirakami G, et al. Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension 1991; 17: 1152-1155.
12. Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger GA, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: A marker of cardio-renal function. Hypertension 2002; 39: 99-104.
13. Yeo KT, Wu AH, Apple FS, Kroll MH, Christenson RH, Lewandrowski KB, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta 2003; 338: 107-115.
14. Kamiya CA, Iwamiya T, Neki R, Katsuragi S, Kawasaki K, Miyoshi T, et al. Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of Fallot. Circ J 2012; 76: 957-963.
15. Apitz C, Sieverding L, Latus H, Uebing A, Schoof S, Hofbeck M. Right ventricular dysfunction and B-type natriuretic peptide in asymptomatic patients after repair for tetralogy of Fallot. Pediatr Cardiol 2009; 30: 898-904.
16. Khositseth A, Manop J, Khowsathit P, Siripornpitak S, Pornkul R, Lolekha P, et al. N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction. Pediatr Cardiol 2007; 28: 333-338.
17. Norozi K, Buchhorn R, Kaiser C, Hess G, Grunewald RW, Binder L, et al. Plasma N-terminal pro-brain natriuretic peptide as a marker of right ventricular dysfunction in patients with tetralogy of Fallot after surgical repair. Chest 2005; 128: 2563-2570.
18. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: A new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644-648.
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
20. Ishii H, Harada K, Toyono M, Tamura M, Takada G. Usefulness of exercise-induced changes in plasma levels of brain natriuretic peptide in predicting right ventricular contractile reserve after repair of tetralogy of Fallot. Am J Cardiol 2005; 95: 1338-1343.
21. Grossman W. Clinical measurement of vascular resistance and assessment of vasodilator drugs. In: Grossman W, editor. Cardiac catheterization and angiography. Philadelphia: Lea and Febiger, 1991; 143-151.
22. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516.
23. Cetin I, Tokel K, Varan B, Orün UA, Gökdemir M, Cindik N, et al. Evaluation of right ventricular functions and B-type natriuretic peptide levels by cardiopulmonary exercise test in patients with pulmonary regurgitation after repair of tetralogy of Fallot. J Card Surg 2008; 23: 493-498.
24. Dodge-Khatami A, Büchel EV, Knirsch W, Kadner A, Rousson V, Dave HH, et al. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation. Ann Thorac Surg 2006; 82: 983-988.
25. Koch AM, Zink S, Glockler M, Seeliger T, Dittrich S. Plasma levels of B-type natriuretic peptide in patients with tetralogy of Fallot after surgical repair. Int J Cardiol 2009; 143: 130-134.
26. Bouzas B, Kilner PJ, Gatzoulis MA. Pulmonary regurgitation: Not a benign lesion. Eur Heart J 2005; 26: 433-439.
27. Redington AN, Oldershaw PJ, Shinebourne EA, Rigby ML. A new technique for the assessment of pulmonary regurgitation and its application to the assessment of right ventricular function before and after repair of tetralogy of Fallot. Br Heart J 1988; 60: 57-65.
28. Therrien J, Siu SC, Harris L, Dore A, Niwa K, Janousek J, et al. Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot. Circulation 2001; 103: 2489-2494.
29. Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003; 108: 2368-2376.
30. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106: 92-99.
31. Hunt PJ, Espiner EA, Nicholls MG, Richards AM, Yandle TG. The role of the circulation in processing pro-brain natriuretic peptide (pro BNP) to amino-terminal BNP and BNP-32. Peptides 1997; 18: 1475-1481.